AMEX:CTEK

Stock Analysis Report

Executive Summary

CynergisTek, Inc., a cybersecurity company, provides various services and solutions to help organizations in achieving privacy, security, and compliance goals for healthcare industry.

Snowflake

Fundamentals

Flawless balance sheet and undervalued.


Similar Companies

Share Price & News

How has CynergisTek's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-7.8%

CTEK

-0.08%

US Healthcare

1.3%

US Market


1 Year Return

-26.3%

CTEK

-10.6%

US Healthcare

5.9%

US Market

Return vs Industry: CTEK underperformed the US Healthcare industry which returned -10.6% over the past year.

Return vs Market: CTEK underperformed the US Market which returned 5.9% over the past year.


Shareholder returns

CTEKIndustryMarket
7 Day-7.8%-0.08%1.3%
30 Day-4.2%-4.1%-1.9%
90 Day-38.9%-9.4%-1.8%
1 Year-26.3%-26.3%-9.2%-10.6%8.3%5.9%
3 Yearn/a28.9%23.7%45.6%36.2%
5 Yearn/a58.9%49.4%66.1%47.9%

Price Volatility Vs. Market

How volatile is CynergisTek's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is CynergisTek undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Undervalued: CTEK ($2.95) is trading below our estimate of fair value ($16.65)

Significantly Undervalued: CTEK is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CTEK is good value based on its PE Ratio (9.5x) compared to the Healthcare industry average (19.9x).

PE vs Market: CTEK is good value based on its PE Ratio (9.5x) compared to the US market (17.5x).


Price to Earnings Growth Ratio

Low PEG Ratio: CTEK's earnings are forecast to decline next year, so we can't calculate its PEG ratio.


Price to Book Ratio

PB vs Industry: CTEK is good value based on its PB Ratio (0.8x) compared to the US Healthcare industry average (2.4x).


Next Steps

Future Growth

How is CynergisTek forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

-75.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CTEK's earnings are forecast to decline over the next 3 years (-75.6% per year).

Earnings vs Market: CTEK's earnings are forecast to decline over the next 3 years (-75.6% per year).

High Growth Earnings: CTEK's earnings are forecast to decline over the next 3 years.

Revenue vs Market: CTEK's revenue (1.8% per year) is forecast to grow slower than the US market (7.3% per year).

High Growth Revenue: CTEK's revenue (1.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

High Future ROE: Insufficient data to determine if CTEK's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has CynergisTek performed over the past 5 years?

-8.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Earnings Trend: CTEK's earnings have declined by -8.5% per year over the past 5 years.

Accelerating Growth: CTEK has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: CTEK has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (5.3%).


Return on Equity

High ROE: CTEK's Return on Equity (8%) is considered low.


Return on Assets

ROA vs Industry: CTEK has a higher Return on Assets than the Healthcare industry average last year.


Return on Capital Employed

ROCE Improving: CTEK's Return on Capital Employed has declined over the past 3 years.


Next Steps

Financial Health

How is CynergisTek's financial position?


Financial Position Analysis

Short Term Liabilities: CTEK's short term assets ($19.4M) exceeds its short term liabilities ($8.3M)

Long Term Liabilities: CTEK's short term assets (19.4M) exceeds its long term liabilities (1.3M)


Debt to Equity History and Analysis

Debt Level: CTEK's debt to equity ratio (4.1%) is considered satisfactory

Reducing Debt: CTEK's debt to equity ratio has reduced from 72.3% to 4.1% over the past 5 years.

Debt Coverage: CTEK's debt is well covered by operating cash flow (235.4%).

Interest Coverage: CTEK's interest payments on its debt are well covered by EBIT (5.2x coverage).


Balance Sheet

Inventory Level: CTEK has a low level of unsold assets or inventory.

Debt Coverage by Assets: CTEK's debt is covered by short term assets (assets are 12.521510x debt).


Next Steps

Dividend

What is CynergisTek's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

companyn/amarketbottom25%1.5%markettop25%3.8%industryaverage1.7%forecastin3Yearsn/a

Current dividend yield vs market & industry


Stability and Growth of Payments

Notable Dividend: Unable to evaluate CTEK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate CTEK's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.

Stable Dividend: Insufficient data to determine if CTEK's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CTEK's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CTEK's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

What is the CEO of CynergisTek's salary, the management and board of directors tenure and is there insider trading?

2.0yrs

Average management tenure


CEO

William Barlow 0

0.2yrs

Tenure

0

Mr. Caleb Barlow has been President and Chief Executive Officer of CynergisTek, Inc. since August 1, 2019. Mr. Barlow is a globally recognized security professional and recently served as Vice President of ...


Management Age and Tenure

2.0yrs

Average Tenure

Experienced Management: CTEK's management team is considered experienced (2 years average tenure).


Board Age and Tenure

2.8yrs

Average Tenure

54yo

Average Age

Experienced Board: CTEK's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Insider Trading

Insider Buying: CTEK insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

BuyUS$28,50012 Sep 19
William Barlow
EntityIndividual
Role
Chief Executive Officer
CEO & President
Shares10,000
Max PriceUS$2.85
BuyUS$19,20027 Aug 19
Mark Roberson
EntityIndividual
Role
Member of the Board of Directors
Director
Shares6,000
Max PriceUS$3.20
BuyUS$33,20023 Aug 19
Judy Krandel
EntityIndividual
Role
Member of the Board of Directors
Director
Shares10,000
Max PriceUS$3.32
BuyUS$33,44220 Aug 19
Paul Anthony
EntityIndividual
Role
Chief Financial Officer
CFO, Corporate Secretary & Treasurer
Shares10,800
Max PriceUS$3.10
BuyUS$32,50020 Aug 19
John Abouchar
EntityIndividual
Role
Chairman of the Board
Non-Executive Chairman of the Board
Shares10,000
Max PriceUS$3.25

Ownership Breakdown


Management Team

  • Paul Anthony (48yo)

    CFO, Corporate Secretary & Treasurer

    • Tenure: 14.8yrs
    • Compensation: US$801.38k
  • Mac McMillan (62yo)

    CEO Emeritus

    • Tenure: 2.8yrs
    • Compensation: US$955.21k
  • Angela Rivera

    Executive Vice President of Operations

    • Tenure: 2yrs
  • Jeremy Molnar

    Senior Vice President of Solution Development

    • Tenure: 0yrs
  • David Finn

    Executive Vice President of Strategic Innovation

    • Tenure: 2yrs
  • Bryan Flynn

    Head of Investor Relations

    • Tenure: 0yrs
  • Michael McCune

    Sales Executive

    • Tenure: 0yrs
    • Compensation: US$494.09k
  • Jana Langhorne

    Senior Director of Marketing

    • Tenure: 0yrs
  • William Barlow

    CEO & President

    • Tenure: 0.2yrs
  • Benjamin Denkers

    Senior Vice President of Security & Privacy Services

    • Tenure: 0.08yrs

Board Members

  • J.D. Abouchar (59yo)

    Non-Executive Chairman of the Board

    • Tenure: 3.4yrs
    • Compensation: US$225.00k
  • Mark Roberson (54yo)

    Director

    • Tenure: 3.4yrs
    • Compensation: US$90.84k
  • Mac McMillan (62yo)

    CEO Emeritus

    • Tenure: 2.8yrs
    • Compensation: US$955.21k
  • Judy Krandel (54yo)

    Director

    • Tenure: 2yrs
    • Compensation: US$59.08k
  • Theresa Meadows (49yo)

    Director

    • Tenure: 2.5yrs
    • Compensation: US$75.33k

Company Information

CynergisTek, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: CynergisTek, Inc.
  • Ticker: CTEK
  • Exchange: AMEX
  • Founded: 1995
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$28.896m
  • Shares outstanding: 9.80m
  • Website: https://www.cynergistek.com

Number of Employees


Location

  • CynergisTek, Inc.
  • 11940 Jollyville Road
  • Suite 300-N
  • Austin
  • Texas
  • 78759
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CTEKAMEX (NYSE MKT LLC)YesCommon StockUSUSDSep 2017

Biography

CynergisTek, Inc., a cybersecurity company, provides various services and solutions to help organizations in achieving privacy, security, and compliance goals for healthcare industry. Its services include  ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/10/15 00:37
End of Day Share Price2019/10/14 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.